Leidos Announces $300M Funding to Accelerate Breakthrough Innovations in National Security & Health

Leidos is thrilled to announce a successful funding round that secured $300,000,000 to further accelerate its mission of addressing some of the world’s most vexing challenges in national security and health. As a Fortune 500® innovation company with a global workforce of 48,000 dedicated professionals, Leidos has consistently delivered smarter technology solutions in heavily regulated industries, and this new capital will enable the company to expand its research and development capabilities and invest in groundbreaking projects. With annual revenues of approximately $15.4 billion reported for the fiscal year ended December 29, 2023, this funding injects fresh momentum into our commitment to innovation and excellence. The funds will support a range of strategic initiatives—from reinforcing our existing technology ecosystem to venturing into new areas that promise transformative impacts on national defense and health. Our team, recognized for its contributions on Forbes’ Best Employers for Diversity, Forbes’ America’s Best Employers for Women, Military Times Best for Vets Employers, and Ethisphere Institute’s World's Most Ethical Companies®, continues to drive progress by addressing challenges with smart, agile solutions. Investing in employee growth and fostering a culture that champions flexibility and work-life balance remain at the core of our operations, as demonstrated by initiatives like our CORE Employee Resource Group. This remarkable investment not only validates the meaningful work our employees perform but also reinforces our leadership in innovation. The expanded resources will empower Leidos to further elevate its technological solutions, drive impactful projects that align with our customers’ missions, and continue to be recognized as an employer of choice in the global market. The future is bright as we embark on this next chapter of growth and positive change.